Oxford upbeat on painkiller
Drug re-developer Oxford Pharmascience (OXP:AIM) believes it is two months away from generating headline data for its chewable version of a 400mg ibuprofen tablet.The company, which makes approved drugs better, safer or easier to...
21 May 2015
